Blood Cancer

Off-the-Shelf CAR T Therapy for DLBCL: Key Facts

by

Off-the-shelf CAR T-cell therapy being tested in clinical trials aims to expand treatment access for diffuse large B-cell lymphoma patients by using healthy donor cells instead of a patient’s own harvested white blood cells. According to blood cancer specialist Dr. John M. Burke of the Rocky Mountain Cancer Center, autologous treatments require complex logistics and … Read more

New Study Uncovers Metabolic Vulnerability in High-Risk Myelodysplastic Syndromes

by

Researchers at the University of Colorado Anschutz Cancer Center have identified a metabolic weakness in the stem cells driving high-risk myelodysplastic syndromes, uncovering an unusual cellular energy dependency that could enable more targeted treatments for the aggressive blood cancer, according to a study published in Blood Cancer Discovery. NAD Dependence in High-Risk MDS Stem Cells … Read more

© 2026 Newsy Today. All rights reserved.


For contact, advertising, copyright, issues email: [email protected]

For contact, advertising, copyright, issues email: [email protected]